Uncovering the immune mechanisms underlying the emergence of immunotherapy-induced pneumonitis in lung cancer patients
Abstract The clinical application of checkpoint inhibitors in lung cancer has been impeded by the emergence of immune-related adverse effects, such as pneumonitis. To date, the precise immune pathogenesis of immune checkpoint inhibitor-related pneumonitis (CIP) remains elusive. Here, we perform comp...
Shranjeno v:
| Principais autores: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Portfolio
2025-11-01
|
| Serija: | Nature Communications |
| Online dostop: | https://doi.org/10.1038/s41467-025-66509-x |
| Oznake: |
Brez oznak, prvi označite!
|
